Andrew Dunn, Kyle LaHucik's Articles

Articles by Andrew Dunn, Kyle LaHucik

What Eikon’s modest IPO says about the future of big-money, big-name biotech - Endpoints News

Business February 6, 2026

For Eikon Therapeutics, its IPO feels more like something its surviving rather than celebrating. The Bay Area startup is one of biotechs most prominent privately

Your trusted source for breaking news, in-depth analysis, and comprehensive coverage of today's most important stories.

Stay Informed with Our Newsletter

Get daily updates on breaking news, exclusive interviews, and special features delivered to your inbox.

Get In Touch

Have a news tip or want to get in touch with our editorial team? We're here to help.

Our Office

Plot C3-C Jaypee Wishtown Sector 129 Noida Uttar Pradesh 201304 India

Email Address

[email protected]

Phone Number

+91-11-26446666

Connect With Us

Quick Links

Home About Us Contact Us Advertise E-Newspaper

Videos Fact Check RSS Feed Track Order Archives

Andrew Dunn, Kyle LaHucik

Articles by Andrew Dunn, Kyle LaHucik

What Eikon’s modest IPO says about the future of big-money, big-name biotech - Endpoints News

Stay Informed with Our Newsletter

Get In Touch

Our Office

Email Address

Phone Number

Connect With Us

Quick Links

Crime & Justice

Browse All Categories

Politics

Business

Health

Technology

Entertainment

Sports

World

Featured

More Categories